Azithromycin as an adjunctive treatment of generalized severe chronic periodontitis: Clinical, microbiologic, and biochemical parameters

Journal of Periodontology

Volumn 83, Issue 12, 2012, Pages 1480-1491

  Han, Buket ^a   Emingil, Gülnur ^a   Özdemir, Güven ^a   Tervahartiala, Taina ^b   Vural, Caner ^a   Atilla, Gül ^a   Baylas, Haluk ^a   Sorsa, Timo ^b,c,d  

^a EGE UNIVERSITY   (Turkey)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d ORTON Invalid Foundation   (Finland)

Author keywords

Antibiotics; Azithromycin; Chronic periodontitis; Gingival crevicular fluid; Matrix metalloproteinase 8; Microbiology

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN; BACTERIAL DNA; NEUTROPHIL COLLAGENASE;

ADJUVANT CHEMOTHERAPY; ADULT; ANALYSIS OF VARIANCE; ARTICLE; BACTERIUM; CHI SQUARE DISTRIBUTION; CHRONIC PERIODONTITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENZYMOLOGY; FEMALE; GENETICS; GINGIVITIS; HUMAN; MALE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; PERIODONTICS; PREVENTIVE DENTISTRY; RANDOMIZED CONTROLLED TRIAL; TOOTH PLAQUE;

ADULT; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BACTERIA; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; CHRONIC PERIODONTITIS; DENTAL PLAQUE; DENTAL SCALING; DNA, BACTERIAL; DOUBLE-BLIND METHOD; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; MALE; MATRIX METALLOPROTEINASE 8; MIDDLE AGED; PERIODONTAL INDEX; STATISTICS, NONPARAMETRIC;

EID: 84871038025     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2012.110519     Document Type: Article

References (47)

1. Kornman KS. Mapping the pathogenesis of periodontitis: A new look. J Periodontol 2008;79(Suppl. 8):1560-1568.
2. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
3. Kornman KS, Page RC, Tonetti MS. The host response to the microbial challenge in periodontitis: Assembling the players. Periodontol 2000 1997;14:33-53.
4. Page RC, Offenbacher S, Schroeder HE, Seymour GJ, Kornman KS. Advances in the pathogenesis of periodontitis: Summary of developments, clinical implications and future directions. Periodontol 2000 1997;14: 216-248.
5. Sorsa T, Tjäderhane L, Konttinen YT, et al. Matrix metalloproteinases: Contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med 2006;38:306-321.
6. Chen HY, Cox SW, Eley BM, Mäntylä P, Rönkä H, Sorsa T. Matrix metalloproteinase-8 levels and elastase activities in gingival crevicular fluid from chronic adult periodontitis patients. J Clin Periodontol 2000;27:366-369.
7. Hernández M, Gamonal J, Tervahartiala T, et al. Associations between matrix metalloproteinase-8 and -14 and myeloperoxidase in gingival crevicular fluid from subjects with progressive chronic periodontitis: A longitudinal study. J Periodontol 2010;81:1644-1652.
8. Page RC. Periodontal therapy: Prospects for the future. J Periodontol 1993;64(Suppl. 8):744-753.
9. Loesche WJ. The antimicrobial treatment of periodontal disease: Changing the treatment paradigm. Crit Rev Oral Biol Med 1999;10:245-275.
10. Haffajee AD, Socransky SS, Gunsolley JC. Systemic anti-infective periodontal therapy. A systematic review. Ann Periodontol 2003;8:115-181.
11. Herrera D, Alonso B, León R, Roldán S, Sanz M. Antimicrobial therapy in periodontitis: The use of systemic antimicrobials against the subgingival biofilm. J Clin Periodontol 2008;35(Suppl. 8):45-66.
12. Foulds G, Shepard RM, Johnson RB. The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother 1990;25(Suppl. A):73-82.
13. Culic̈ O, Erakovic̈ V, Parnham MJ. Anti-inflammatory effects of macrolide antibiotics. Eur J Pharmacol 2001;429:209-229.
14. Malizia T, Tejada MR, Ghelardi E, et al. Periodontal tissue disposition of azithromycin. J Periodontol 1997;68:1206-1209.
15. Blandizzi C, Malizia T, Lupetti A, et al. Periodontal tissue disposition of azithromycin in patients affected by chronic inflammatory periodontal diseases. J Periodontol 1999;70:960-966.
16. Gomi K, Yashima A, Iino F, et al. Drug concentration in inflamed periodontal tissues after systemically administered azithromycin. J Periodontol 2007;78:918-923.
17. Smith SR, Foyle DM, Daniels J, et al. A double-blind placebo-controlled trial of azithromycin as an adjunct to non-surgical treatment of periodontitis in adults: Clinical results. J Clin Periodontol 2002;29:54-61.
18. Mascarenhas P, Gapski R, Al-Shammari K, et al. Clinical response of azithromycin as an adjunct to non-surgical periodontal therapy in smokers. J Periodontol 2005;76:426-436.
19. Haffajee AD, Torresyap G, Socransky SS. Clinical changes following four different periodontal therapies for the treatment of chronic periodontitis: 1-year results. J Clin Periodontol 2007;34:243-253.
20. Gomi K, Yashima A, Nagano T, Kanazashi M, Maeda N, Arai T. Effects of full-mouth scaling and root planing in conjunction with systemically administered azithromycin. J Periodontol 2007;78:422-429.
21. Yashima A, Gomi K, Maeda N, Arai T. One-stage fullmouth versus partial-mouth scaling and root planing during the effective half-life of systemically administered azithromycin. J Periodontol 2009;80:1406-1413.
22. Dastoor SF, Travan S, Neiva RF, Rayburn LA, Giannobile WV, Wang HL. Effect of adjunctive systemic azithromycin with periodontal surgery in the treatment of chronic periodontitis in smokers: A pilot study. J Periodontol 2007;78:1887-1896.
23. Oteo A, Herrera D, Figuero E, O'Connor A, Gonzá lez I, Sanz M. Azithromycin as an adjunct to scaling and root planing in the treatment of Porphyromonas gingivalisassociated periodontitis: A pilot study. J Clin Periodontol 2010;37:1005-1015.
24. Haas AN, de Castro GD, Moreno T, et al. Azithromycin as an adjunctive treatment of aggressive periodontitis: 12-months randomized clinical trial. J Clin Periodontol 2008;35:696-704.
25. Sampaio E, Rocha M, Figueiredo LC, et al. Clinical and microbiological effects of azithromycin in the treatment of generalized chronic periodontitis: A randomized placebo-controlled clinical trial. J Clin Periodontol 2011;38:838-846.
26. Flemming TF. Periodontitis. Ann Periodontol 1999;4: 32-37.
27. Lamster IB, Hartley LJ, Vogel RI. Development of a biochemical profile for gingival crevicular fluid. Methodological considerations and evaluation of collagendegrading and ground substance-degrading enzyme activity during experimental gingivitis. J Periodontol 1985;56(Suppl. 11):13-21.
28. Cimasoni G. Method of collection. In: Crevicular Fluid Updated. Basel: Karger;1983:29-36.
29. Hanemaaijer R, Sorsa T, Konttinen YT, et al. Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-α and doxycycline. J Biol Chem 1997;272:31504-31509.
30. Becerik S, Türkoglu O, Emingil G, Vural C, Özdemir G, Atilla G. Anti-microbial effect of adjunctive use of chlorhexidine mouthrinse in untreated gingivitis: A randomized, placebo-controlled study. APMIS 2011;119:364-372.
31. American Academy of Periodontology. Parameter on chronic periodontitis with slight to moderate loss of periodontal support. J Periodontol 2000;71(Suppl. 5): 853-855.
32. American Academy of Periodontology. Parameter on chronic periodontitis with advanced loss of periodontal support. J Periodontol 2000;71(Suppl. 5):856-858.
33. Cobb CM. Non-surgical pocket therapy: Mechanical. Ann Periodontol 1996;1:443-490.
34. Hung HC, Douglass CW. Meta-analysis of the effect of scaling and root planing, surgical treatment and antibiotic therapies on periodontal probing depth and attachment loss. J Clin Periodontol 2002;29:975-986.
35. Loesche WJ, Giordano JR. Metronidazole in periodontitis V: Debridement should precede medication. Compendium 1994;15: 1198-1201, 1201, 1203 passim, quiz 1218.
36. Socransky SS, Haffajee AD. Dental biofilms: Difficult therapeutic targets. Periodontol 2000 2002;28:12-55.
37. Sanz M, Teughels W; Group A of European Workshop on Periodontology. Innovations in non-surgical periodontal therapy: Consensus Report of the Sixth European Workshop on Periodontology. J Clin Periodontol 2008;35(Suppl. 8):3-7.
38. Mäntylä P, Stenman M, Kinane DF, et al. Gingival crevicular fluid collagenase-2 (MMP-8) test stick for chair-side monitoring of periodontitis. J Periodontal Res 2003;38:436-439.
39. Marcaccini AM, Meschiari CA, Zuardi LR, et al. Gingival crevicular fluid levels of MMP-8, MMP-9, TIMP-2, and MPO decrease after periodontal therapy. J Clin Periodontol 2010;37:180-190.
40. Socransky SS, Haffajee AD. The bacterial etiology of destructive periodontal disease: Current concepts. J Periodontol 1992;63(Suppl. 4):322-331.
41. Teles RP, Haffajee AD, Socransky SS. Microbiological goals of periodontal therapy. Periodontol 2000 2006;42:180-218.
42. Haffajee AD, Teles RP, Socransky SS. The effect of periodontal therapy on the composition of the subgingival microbiota. Periodontol 2000 2006;42:219-258.
43. Umeda M, Takeuchi Y, Noguchi K, Huang Y, Koshy G, Ishikawa I. Effects of nonsurgical periodontal therapy on the microbiota. Periodontol 2000 2004;36:98-120.
44. Pajukanta R. In vitro antimicrobial susceptibility of Porphyromonas gingivalis to azithromycin, A novel macrolide. Oral Microbiol Immunol 1993;8:325-326.
45. Sefton AM, Maskell JP, Beighton D, et al. Azithromycin in the treatment of periodontal disease. Effect on microbial flora. J Clin Periodontol 1996;23:998-1003.
46. American Academy of Periodontology. Parameter on periodontal maintenance. J Periodontol 2000;71 (Suppl. 5):849-850.
47. Rooney J, Wade WG, Sprague SV, Newcombe RG, Addy M. Adjunctive effects to non-surgical periodontal therapy of systemic metronidazole and amoxycillin alone and combined. A placebo controlled study. J Clin Periodontol 2002;29:342-350.